Table 3.
Univariable analysis of the association between TSPS-phasic and TSPS-tonic with other baseline characteristics.
Variable | TSPS-phasic | TSPS-tonic | ||
---|---|---|---|---|
Correlation coefficient1 | p-Value | Correlation coefficient1 | p-Value | |
TSPS-tonic | 0.108 | 0.445 | 1.00 | – |
TSPS-phasic | 1.00 | – | 0.108 | 0.445 |
Age | −0.249 | 0.075 | −0.049 | 0.732 |
BDI | 0.019 | 0.894 | 0.024 | 0.867 |
BMI | 0.073 | 0.605 | −0.020 | 0.686 |
Opioid use | −0.06 | 0.652 | −0.01 | 0.89 |
BPI pain | 0.147 | 0.298 | −0.057 | 0.686 |
BPI interference | −0.020 | 0.887 | −0.115 | 0.418 |
BPI number of locations with pain | 0.1 | 0.477 | 0.18 | 0.199 |
CPM | −0.973 | 0.492 | 0.085 | 0.547 |
Duration | −0.330 | 0.017 | 0.055 | 0.696 |
FIQR | 0.035 | 0.804 | 0.007 | 0.960 |
Pain-60 | 0.102 | 0.474 | 0.164 | 0.246 |
PSQI | −0.080 | 0.571 | 0.035 | 0.805 |
QOLS | 0.032 | 0.823 | −0.208 | 0.139 |
VAS pain | 0.064 | 0.651 | −0.209 | 0.137 |
VAS anxiety | 0.071 | 0.618 | 0.116 | 0.413 |
VAS depression | 0.057 | 0.688 | −0.045 | 0.753 |
VAS sleepiness | −0.199 | 0.158 | 0.062 | 0.661 |
VAS stress | −0.043 | 0.761 | −0.129 | 0.362 |
PROMIS anxiety | 0.071 | 0.616 | −0.022 | 0.875 |
PROMIS fatigue | −0.191 | 0.175 | 0.141 | 0.318 |
PROMIS pain | 0.066 | 0.643 | −0.090 | 0.524 |
Variable | Mean difference 2 | p -Value | Mean difference 2 | p -Value |
Female | −1.265 | 0.082 | −0.362 | 0.668 |
White | 0.255 | 0.646 | 0.721 | 0.251 |
Hispanic | 0.188 | 0.769 | −0.514 | 0.480 |
1Pearson correlation.
2Unpaired t-test.
PROMIS, Patient-Reported Outcomes Measurement Information System; VAS, Visual Analog Scale; PSQI, Pittsburgh Sleep Quality Index; FIQR, Revised Fibromyalgia Impact Questionnaire; BPI, Beck's Depression Inventory; BDI, Brief Depression Inventory; QOLS, Quality of Life Scale.